Principia Biopharma Announces Positive Data from Phase 2 Pemphigus Vulgaris Trial at 2019 American Academy of Dermatology Annual Meeting in Late-Breaking Presentation March 2, 2019 - NASDAQ Companies 0 » View More News for March 02, 2019